nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR6—Raloxifene—osteoporosis	0.12	0.249	CbGbCtD
Aripiprazole—HTR2B—Raloxifene—osteoporosis	0.107	0.222	CbGbCtD
Aripiprazole—CYP3A7—Estradiol—osteoporosis	0.0282	0.0587	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0282	0.0587	CbGbCtD
Aripiprazole—ABCB1—Ethinyl Estradiol—osteoporosis	0.0214	0.0445	CbGbCtD
Aripiprazole—CYP3A5—Estradiol—osteoporosis	0.0212	0.044	CbGbCtD
Aripiprazole—CYP3A4—Estropipate—osteoporosis	0.0199	0.0413	CbGbCtD
Aripiprazole—CYP3A4—Calcitriol—osteoporosis	0.0199	0.0413	CbGbCtD
Aripiprazole—CYP2D6—Cholecalciferol—osteoporosis	0.0161	0.0335	CbGbCtD
Aripiprazole—CYP3A4—Ergocalciferol—osteoporosis	0.0159	0.0331	CbGbCtD
Aripiprazole—ABCB1—Conjugated Estrogens—osteoporosis	0.0157	0.0326	CbGbCtD
Aripiprazole—ABCB1—Estradiol—osteoporosis	0.0138	0.0287	CbGbCtD
Aripiprazole—CYP3A4—Raloxifene—osteoporosis	0.0133	0.0276	CbGbCtD
Aripiprazole—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0128	0.0266	CbGbCtD
Aripiprazole—CYP3A4—Cholecalciferol—osteoporosis	0.0102	0.0213	CbGbCtD
Aripiprazole—CYP3A4—Conjugated Estrogens—osteoporosis	0.0094	0.0196	CbGbCtD
Aripiprazole—CYP3A4—Estradiol—osteoporosis	0.00826	0.0172	CbGbCtD
Aripiprazole—Pruritus—Alendronate—osteoporosis	9.17e-05	0.000234	CcSEcCtD
Aripiprazole—Dyspepsia—Risedronate—osteoporosis	9.15e-05	0.000233	CcSEcCtD
Aripiprazole—Eye disorder—Estradiol—osteoporosis	9.15e-05	0.000233	CcSEcCtD
Aripiprazole—Tinnitus—Estradiol—osteoporosis	9.13e-05	0.000233	CcSEcCtD
Aripiprazole—Constipation—Ethinyl Estradiol—osteoporosis	9.12e-05	0.000233	CcSEcCtD
Aripiprazole—Confusional state—Zoledronate—osteoporosis	9.1e-05	0.000232	CcSEcCtD
Aripiprazole—Hypersensitivity—Calcitriol—osteoporosis	9.1e-05	0.000232	CcSEcCtD
Aripiprazole—Flushing—Estradiol—osteoporosis	9.09e-05	0.000232	CcSEcCtD
Aripiprazole—Cardiac disorder—Estradiol—osteoporosis	9.09e-05	0.000232	CcSEcCtD
Aripiprazole—Myalgia—Conjugated Estrogens—osteoporosis	9.07e-05	0.000231	CcSEcCtD
Aripiprazole—Chest pain—Conjugated Estrogens—osteoporosis	9.07e-05	0.000231	CcSEcCtD
Aripiprazole—Arthralgia—Conjugated Estrogens—osteoporosis	9.07e-05	0.000231	CcSEcCtD
Aripiprazole—Asthenia—Ibandronate—osteoporosis	9.05e-05	0.000231	CcSEcCtD
Aripiprazole—Anxiety—Conjugated Estrogens—osteoporosis	9.04e-05	0.00023	CcSEcCtD
Aripiprazole—Nausea—Etidronic acid—osteoporosis	9.03e-05	0.00023	CcSEcCtD
Aripiprazole—Oedema—Zoledronate—osteoporosis	9.03e-05	0.00023	CcSEcCtD
Aripiprazole—Anaphylactic shock—Zoledronate—osteoporosis	9.03e-05	0.00023	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9e-05	0.00023	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Pamidronate—osteoporosis	9e-05	0.00023	CcSEcCtD
Aripiprazole—Diarrhoea—Estropipate—osteoporosis	9e-05	0.00023	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Risedronate—osteoporosis	8.98e-05	0.000229	CcSEcCtD
Aripiprazole—Infection—Zoledronate—osteoporosis	8.97e-05	0.000229	CcSEcCtD
Aripiprazole—Fatigue—Risedronate—osteoporosis	8.96e-05	0.000229	CcSEcCtD
Aripiprazole—Insomnia—Pamidronate—osteoporosis	8.94e-05	0.000228	CcSEcCtD
Aripiprazole—Pruritus—Ibandronate—osteoporosis	8.92e-05	0.000228	CcSEcCtD
Aripiprazole—Pain—Risedronate—osteoporosis	8.89e-05	0.000227	CcSEcCtD
Aripiprazole—Constipation—Risedronate—osteoporosis	8.89e-05	0.000227	CcSEcCtD
Aripiprazole—Angiopathy—Estradiol—osteoporosis	8.88e-05	0.000227	CcSEcCtD
Aripiprazole—Shock—Zoledronate—osteoporosis	8.88e-05	0.000227	CcSEcCtD
Aripiprazole—Paraesthesia—Pamidronate—osteoporosis	8.87e-05	0.000226	CcSEcCtD
Aripiprazole—Diarrhoea—Alendronate—osteoporosis	8.86e-05	0.000226	CcSEcCtD
Aripiprazole—Asthenia—Calcitriol—osteoporosis	8.86e-05	0.000226	CcSEcCtD
Aripiprazole—Nervous system disorder—Zoledronate—osteoporosis	8.85e-05	0.000226	CcSEcCtD
Aripiprazole—Immune system disorder—Estradiol—osteoporosis	8.84e-05	0.000226	CcSEcCtD
Aripiprazole—Thrombocytopenia—Zoledronate—osteoporosis	8.84e-05	0.000225	CcSEcCtD
Aripiprazole—Mediastinal disorder—Estradiol—osteoporosis	8.82e-05	0.000225	CcSEcCtD
Aripiprazole—Dyspnoea—Pamidronate—osteoporosis	8.81e-05	0.000225	CcSEcCtD
Aripiprazole—Tachycardia—Zoledronate—osteoporosis	8.81e-05	0.000225	CcSEcCtD
Aripiprazole—Feeling abnormal—Ethinyl Estradiol—osteoporosis	8.79e-05	0.000224	CcSEcCtD
Aripiprazole—Chills—Estradiol—osteoporosis	8.79e-05	0.000224	CcSEcCtD
Aripiprazole—Somnolence—Pamidronate—osteoporosis	8.79e-05	0.000224	CcSEcCtD
Aripiprazole—Skin disorder—Zoledronate—osteoporosis	8.77e-05	0.000224	CcSEcCtD
Aripiprazole—Pruritus—Calcitriol—osteoporosis	8.74e-05	0.000223	CcSEcCtD
Aripiprazole—Hyperhidrosis—Zoledronate—osteoporosis	8.73e-05	0.000223	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	8.72e-05	0.000222	CcSEcCtD
Aripiprazole—Diarrhoea—Raloxifene—osteoporosis	8.72e-05	0.000222	CcSEcCtD
Aripiprazole—Dyspepsia—Pamidronate—osteoporosis	8.7e-05	0.000222	CcSEcCtD
Aripiprazole—Dizziness—Estropipate—osteoporosis	8.7e-05	0.000222	CcSEcCtD
Aripiprazole—Anaphylactic shock—Conjugated Estrogens—osteoporosis	8.69e-05	0.000222	CcSEcCtD
Aripiprazole—Oedema—Conjugated Estrogens—osteoporosis	8.69e-05	0.000222	CcSEcCtD
Aripiprazole—Alopecia—Estradiol—osteoporosis	8.65e-05	0.000221	CcSEcCtD
Aripiprazole—Infection—Conjugated Estrogens—osteoporosis	8.64e-05	0.00022	CcSEcCtD
Aripiprazole—Diarrhoea—Ibandronate—osteoporosis	8.63e-05	0.00022	CcSEcCtD
Aripiprazole—Anorexia—Zoledronate—osteoporosis	8.6e-05	0.000219	CcSEcCtD
Aripiprazole—Decreased appetite—Pamidronate—osteoporosis	8.59e-05	0.000219	CcSEcCtD
Aripiprazole—Mental disorder—Estradiol—osteoporosis	8.58e-05	0.000219	CcSEcCtD
Aripiprazole—Dizziness—Alendronate—osteoporosis	8.57e-05	0.000219	CcSEcCtD
Aripiprazole—Shock—Conjugated Estrogens—osteoporosis	8.55e-05	0.000218	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Pamidronate—osteoporosis	8.53e-05	0.000218	CcSEcCtD
Aripiprazole—Nervous system disorder—Conjugated Estrogens—osteoporosis	8.52e-05	0.000217	CcSEcCtD
Aripiprazole—Erythema—Estradiol—osteoporosis	8.52e-05	0.000217	CcSEcCtD
Aripiprazole—Malnutrition—Estradiol—osteoporosis	8.52e-05	0.000217	CcSEcCtD
Aripiprazole—Fatigue—Pamidronate—osteoporosis	8.52e-05	0.000217	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Risedronate—osteoporosis	8.5e-05	0.000217	CcSEcCtD
Aripiprazole—Tachycardia—Conjugated Estrogens—osteoporosis	8.48e-05	0.000216	CcSEcCtD
Aripiprazole—Urticaria—Ethinyl Estradiol—osteoporosis	8.47e-05	0.000216	CcSEcCtD
Aripiprazole—Constipation—Pamidronate—osteoporosis	8.45e-05	0.000216	CcSEcCtD
Aripiprazole—Pain—Pamidronate—osteoporosis	8.45e-05	0.000216	CcSEcCtD
Aripiprazole—Diarrhoea—Calcitriol—osteoporosis	8.45e-05	0.000216	CcSEcCtD
Aripiprazole—Skin disorder—Conjugated Estrogens—osteoporosis	8.44e-05	0.000215	CcSEcCtD
Aripiprazole—Hypotension—Zoledronate—osteoporosis	8.44e-05	0.000215	CcSEcCtD
Aripiprazole—Abdominal pain—Ethinyl Estradiol—osteoporosis	8.43e-05	0.000215	CcSEcCtD
Aripiprazole—Body temperature increased—Ethinyl Estradiol—osteoporosis	8.43e-05	0.000215	CcSEcCtD
Aripiprazole—Dizziness—Raloxifene—osteoporosis	8.43e-05	0.000215	CcSEcCtD
Aripiprazole—Hyperhidrosis—Conjugated Estrogens—osteoporosis	8.4e-05	0.000214	CcSEcCtD
Aripiprazole—Flatulence—Estradiol—osteoporosis	8.4e-05	0.000214	CcSEcCtD
Aripiprazole—Tension—Estradiol—osteoporosis	8.36e-05	0.000213	CcSEcCtD
Aripiprazole—Vomiting—Estropipate—osteoporosis	8.36e-05	0.000213	CcSEcCtD
Aripiprazole—Dysgeusia—Estradiol—osteoporosis	8.35e-05	0.000213	CcSEcCtD
Aripiprazole—Dizziness—Ibandronate—osteoporosis	8.34e-05	0.000213	CcSEcCtD
Aripiprazole—Rash—Estropipate—osteoporosis	8.29e-05	0.000212	CcSEcCtD
Aripiprazole—Dermatitis—Estropipate—osteoporosis	8.29e-05	0.000211	CcSEcCtD
Aripiprazole—Anorexia—Conjugated Estrogens—osteoporosis	8.29e-05	0.000211	CcSEcCtD
Aripiprazole—Nervousness—Estradiol—osteoporosis	8.28e-05	0.000211	CcSEcCtD
Aripiprazole—Urticaria—Risedronate—osteoporosis	8.26e-05	0.000211	CcSEcCtD
Aripiprazole—Back pain—Estradiol—osteoporosis	8.24e-05	0.00021	CcSEcCtD
Aripiprazole—Headache—Estropipate—osteoporosis	8.24e-05	0.00021	CcSEcCtD
Aripiprazole—Vomiting—Alendronate—osteoporosis	8.24e-05	0.00021	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Zoledronate—osteoporosis	8.22e-05	0.00021	CcSEcCtD
Aripiprazole—Abdominal pain—Risedronate—osteoporosis	8.22e-05	0.00021	CcSEcCtD
Aripiprazole—Body temperature increased—Risedronate—osteoporosis	8.22e-05	0.00021	CcSEcCtD
Aripiprazole—Muscle spasms—Estradiol—osteoporosis	8.19e-05	0.000209	CcSEcCtD
Aripiprazole—Rash—Alendronate—osteoporosis	8.17e-05	0.000208	CcSEcCtD
Aripiprazole—Insomnia—Zoledronate—osteoporosis	8.16e-05	0.000208	CcSEcCtD
Aripiprazole—Dermatitis—Alendronate—osteoporosis	8.16e-05	0.000208	CcSEcCtD
Aripiprazole—Feeling abnormal—Pamidronate—osteoporosis	8.14e-05	0.000208	CcSEcCtD
Aripiprazole—Hypotension—Conjugated Estrogens—osteoporosis	8.12e-05	0.000207	CcSEcCtD
Aripiprazole—Headache—Alendronate—osteoporosis	8.12e-05	0.000207	CcSEcCtD
Aripiprazole—Paraesthesia—Zoledronate—osteoporosis	8.11e-05	0.000207	CcSEcCtD
Aripiprazole—Vomiting—Raloxifene—osteoporosis	8.1e-05	0.000207	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Pamidronate—osteoporosis	8.08e-05	0.000206	CcSEcCtD
Aripiprazole—Dyspnoea—Zoledronate—osteoporosis	8.05e-05	0.000205	CcSEcCtD
Aripiprazole—Rash—Raloxifene—osteoporosis	8.03e-05	0.000205	CcSEcCtD
Aripiprazole—Dermatitis—Raloxifene—osteoporosis	8.03e-05	0.000205	CcSEcCtD
Aripiprazole—Somnolence—Zoledronate—osteoporosis	8.02e-05	0.000205	CcSEcCtD
Aripiprazole—Vomiting—Ibandronate—osteoporosis	8.02e-05	0.000205	CcSEcCtD
Aripiprazole—Tremor—Estradiol—osteoporosis	7.99e-05	0.000204	CcSEcCtD
Aripiprazole—Headache—Raloxifene—osteoporosis	7.98e-05	0.000204	CcSEcCtD
Aripiprazole—Rash—Ibandronate—osteoporosis	7.95e-05	0.000203	CcSEcCtD
Aripiprazole—Dermatitis—Ibandronate—osteoporosis	7.95e-05	0.000203	CcSEcCtD
Aripiprazole—Dyspepsia—Zoledronate—osteoporosis	7.95e-05	0.000203	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	7.92e-05	0.000202	CcSEcCtD
Aripiprazole—Ill-defined disorder—Estradiol—osteoporosis	7.91e-05	0.000202	CcSEcCtD
Aripiprazole—Headache—Ibandronate—osteoporosis	7.9e-05	0.000202	CcSEcCtD
Aripiprazole—Insomnia—Conjugated Estrogens—osteoporosis	7.86e-05	0.000201	CcSEcCtD
Aripiprazole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	7.86e-05	0.0002	CcSEcCtD
Aripiprazole—Vomiting—Calcitriol—osteoporosis	7.85e-05	0.0002	CcSEcCtD
Aripiprazole—Decreased appetite—Zoledronate—osteoporosis	7.85e-05	0.0002	CcSEcCtD
Aripiprazole—Agitation—Estradiol—osteoporosis	7.83e-05	0.0002	CcSEcCtD
Aripiprazole—Nausea—Estropipate—osteoporosis	7.81e-05	0.000199	CcSEcCtD
Aripiprazole—Abdominal pain—Pamidronate—osteoporosis	7.81e-05	0.000199	CcSEcCtD
Aripiprazole—Body temperature increased—Pamidronate—osteoporosis	7.81e-05	0.000199	CcSEcCtD
Aripiprazole—Paraesthesia—Conjugated Estrogens—osteoporosis	7.8e-05	0.000199	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Zoledronate—osteoporosis	7.79e-05	0.000199	CcSEcCtD
Aripiprazole—Angioedema—Estradiol—osteoporosis	7.79e-05	0.000199	CcSEcCtD
Aripiprazole—Rash—Calcitriol—osteoporosis	7.79e-05	0.000199	CcSEcCtD
Aripiprazole—Fatigue—Zoledronate—osteoporosis	7.78e-05	0.000199	CcSEcCtD
Aripiprazole—Dermatitis—Calcitriol—osteoporosis	7.78e-05	0.000198	CcSEcCtD
Aripiprazole—Dyspnoea—Conjugated Estrogens—osteoporosis	7.75e-05	0.000198	CcSEcCtD
Aripiprazole—Headache—Calcitriol—osteoporosis	7.74e-05	0.000197	CcSEcCtD
Aripiprazole—Somnolence—Conjugated Estrogens—osteoporosis	7.73e-05	0.000197	CcSEcCtD
Aripiprazole—Pain—Zoledronate—osteoporosis	7.72e-05	0.000197	CcSEcCtD
Aripiprazole—Constipation—Zoledronate—osteoporosis	7.72e-05	0.000197	CcSEcCtD
Aripiprazole—Nausea—Alendronate—osteoporosis	7.7e-05	0.000196	CcSEcCtD
Aripiprazole—Malaise—Estradiol—osteoporosis	7.69e-05	0.000196	CcSEcCtD
Aripiprazole—Hypersensitivity—Risedronate—osteoporosis	7.66e-05	0.000195	CcSEcCtD
Aripiprazole—Vertigo—Estradiol—osteoporosis	7.66e-05	0.000195	CcSEcCtD
Aripiprazole—Dyspepsia—Conjugated Estrogens—osteoporosis	7.65e-05	0.000195	CcSEcCtD
Aripiprazole—Asthenia—Ethinyl Estradiol—osteoporosis	7.65e-05	0.000195	CcSEcCtD
Aripiprazole—Syncope—Estradiol—osteoporosis	7.64e-05	0.000195	CcSEcCtD
Aripiprazole—Nausea—Raloxifene—osteoporosis	7.57e-05	0.000193	CcSEcCtD
Aripiprazole—Decreased appetite—Conjugated Estrogens—osteoporosis	7.56e-05	0.000193	CcSEcCtD
Aripiprazole—Pruritus—Ethinyl Estradiol—osteoporosis	7.54e-05	0.000192	CcSEcCtD
Aripiprazole—Palpitations—Estradiol—osteoporosis	7.53e-05	0.000192	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	7.5e-05	0.000191	CcSEcCtD
Aripiprazole—Fatigue—Conjugated Estrogens—osteoporosis	7.49e-05	0.000191	CcSEcCtD
Aripiprazole—Nausea—Ibandronate—osteoporosis	7.49e-05	0.000191	CcSEcCtD
Aripiprazole—Loss of consciousness—Estradiol—osteoporosis	7.49e-05	0.000191	CcSEcCtD
Aripiprazole—Asthenia—Risedronate—osteoporosis	7.46e-05	0.00019	CcSEcCtD
Aripiprazole—Feeling abnormal—Zoledronate—osteoporosis	7.44e-05	0.00019	CcSEcCtD
Aripiprazole—Cough—Estradiol—osteoporosis	7.44e-05	0.00019	CcSEcCtD
Aripiprazole—Pain—Conjugated Estrogens—osteoporosis	7.43e-05	0.00019	CcSEcCtD
Aripiprazole—Constipation—Conjugated Estrogens—osteoporosis	7.43e-05	0.00019	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Zoledronate—osteoporosis	7.38e-05	0.000188	CcSEcCtD
Aripiprazole—Hypertension—Estradiol—osteoporosis	7.36e-05	0.000188	CcSEcCtD
Aripiprazole—Pruritus—Risedronate—osteoporosis	7.36e-05	0.000188	CcSEcCtD
Aripiprazole—Nausea—Calcitriol—osteoporosis	7.33e-05	0.000187	CcSEcCtD
Aripiprazole—Diarrhoea—Ethinyl Estradiol—osteoporosis	7.3e-05	0.000186	CcSEcCtD
Aripiprazole—Hypersensitivity—Pamidronate—osteoporosis	7.28e-05	0.000186	CcSEcCtD
Aripiprazole—Chest pain—Estradiol—osteoporosis	7.26e-05	0.000185	CcSEcCtD
Aripiprazole—Arthralgia—Estradiol—osteoporosis	7.26e-05	0.000185	CcSEcCtD
Aripiprazole—Myalgia—Estradiol—osteoporosis	7.26e-05	0.000185	CcSEcCtD
Aripiprazole—Anxiety—Estradiol—osteoporosis	7.23e-05	0.000184	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.21e-05	0.000184	CcSEcCtD
Aripiprazole—Urticaria—Zoledronate—osteoporosis	7.17e-05	0.000183	CcSEcCtD
Aripiprazole—Discomfort—Estradiol—osteoporosis	7.17e-05	0.000183	CcSEcCtD
Aripiprazole—Abdominal pain—Zoledronate—osteoporosis	7.14e-05	0.000182	CcSEcCtD
Aripiprazole—Body temperature increased—Zoledronate—osteoporosis	7.14e-05	0.000182	CcSEcCtD
Aripiprazole—Diarrhoea—Risedronate—osteoporosis	7.11e-05	0.000181	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.11e-05	0.000181	CcSEcCtD
Aripiprazole—Dry mouth—Estradiol—osteoporosis	7.1e-05	0.000181	CcSEcCtD
Aripiprazole—Asthenia—Pamidronate—osteoporosis	7.09e-05	0.000181	CcSEcCtD
Aripiprazole—Dizziness—Ethinyl Estradiol—osteoporosis	7.05e-05	0.00018	CcSEcCtD
Aripiprazole—Confusional state—Estradiol—osteoporosis	7.01e-05	0.000179	CcSEcCtD
Aripiprazole—Pruritus—Pamidronate—osteoporosis	6.99e-05	0.000178	CcSEcCtD
Aripiprazole—Anaphylactic shock—Estradiol—osteoporosis	6.96e-05	0.000177	CcSEcCtD
Aripiprazole—Oedema—Estradiol—osteoporosis	6.96e-05	0.000177	CcSEcCtD
Aripiprazole—Infection—Estradiol—osteoporosis	6.91e-05	0.000176	CcSEcCtD
Aripiprazole—Urticaria—Conjugated Estrogens—osteoporosis	6.91e-05	0.000176	CcSEcCtD
Aripiprazole—Dizziness—Risedronate—osteoporosis	6.87e-05	0.000175	CcSEcCtD
Aripiprazole—Abdominal pain—Conjugated Estrogens—osteoporosis	6.87e-05	0.000175	CcSEcCtD
Aripiprazole—Body temperature increased—Conjugated Estrogens—osteoporosis	6.87e-05	0.000175	CcSEcCtD
Aripiprazole—Shock—Estradiol—osteoporosis	6.84e-05	0.000175	CcSEcCtD
Aripiprazole—Nervous system disorder—Estradiol—osteoporosis	6.82e-05	0.000174	CcSEcCtD
Aripiprazole—Tachycardia—Estradiol—osteoporosis	6.79e-05	0.000173	CcSEcCtD
Aripiprazole—Vomiting—Ethinyl Estradiol—osteoporosis	6.78e-05	0.000173	CcSEcCtD
Aripiprazole—Diarrhoea—Pamidronate—osteoporosis	6.76e-05	0.000172	CcSEcCtD
Aripiprazole—Skin disorder—Estradiol—osteoporosis	6.76e-05	0.000172	CcSEcCtD
Aripiprazole—Hyperhidrosis—Estradiol—osteoporosis	6.73e-05	0.000172	CcSEcCtD
Aripiprazole—Rash—Ethinyl Estradiol—osteoporosis	6.72e-05	0.000171	CcSEcCtD
Aripiprazole—Dermatitis—Ethinyl Estradiol—osteoporosis	6.72e-05	0.000171	CcSEcCtD
Aripiprazole—Headache—Ethinyl Estradiol—osteoporosis	6.68e-05	0.00017	CcSEcCtD
Aripiprazole—Hypersensitivity—Zoledronate—osteoporosis	6.65e-05	0.00017	CcSEcCtD
Aripiprazole—Vomiting—Risedronate—osteoporosis	6.61e-05	0.000169	CcSEcCtD
Aripiprazole—Rash—Risedronate—osteoporosis	6.55e-05	0.000167	CcSEcCtD
Aripiprazole—Dermatitis—Risedronate—osteoporosis	6.55e-05	0.000167	CcSEcCtD
Aripiprazole—Dizziness—Pamidronate—osteoporosis	6.54e-05	0.000167	CcSEcCtD
Aripiprazole—Headache—Risedronate—osteoporosis	6.51e-05	0.000166	CcSEcCtD
Aripiprazole—Asthenia—Zoledronate—osteoporosis	6.48e-05	0.000165	CcSEcCtD
Aripiprazole—Hypersensitivity—Conjugated Estrogens—osteoporosis	6.4e-05	0.000163	CcSEcCtD
Aripiprazole—Pruritus—Zoledronate—osteoporosis	6.39e-05	0.000163	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Estradiol—osteoporosis	6.34e-05	0.000162	CcSEcCtD
Aripiprazole—Nausea—Ethinyl Estradiol—osteoporosis	6.33e-05	0.000162	CcSEcCtD
Aripiprazole—Insomnia—Estradiol—osteoporosis	6.29e-05	0.000161	CcSEcCtD
Aripiprazole—Vomiting—Pamidronate—osteoporosis	6.28e-05	0.00016	CcSEcCtD
Aripiprazole—Paraesthesia—Estradiol—osteoporosis	6.25e-05	0.000159	CcSEcCtD
Aripiprazole—Asthenia—Conjugated Estrogens—osteoporosis	6.24e-05	0.000159	CcSEcCtD
Aripiprazole—Rash—Pamidronate—osteoporosis	6.23e-05	0.000159	CcSEcCtD
Aripiprazole—Dermatitis—Pamidronate—osteoporosis	6.23e-05	0.000159	CcSEcCtD
Aripiprazole—Dyspnoea—Estradiol—osteoporosis	6.2e-05	0.000158	CcSEcCtD
Aripiprazole—Headache—Pamidronate—osteoporosis	6.19e-05	0.000158	CcSEcCtD
Aripiprazole—Somnolence—Estradiol—osteoporosis	6.18e-05	0.000158	CcSEcCtD
Aripiprazole—Diarrhoea—Zoledronate—osteoporosis	6.18e-05	0.000158	CcSEcCtD
Aripiprazole—Nausea—Risedronate—osteoporosis	6.18e-05	0.000158	CcSEcCtD
Aripiprazole—Pruritus—Conjugated Estrogens—osteoporosis	6.15e-05	0.000157	CcSEcCtD
Aripiprazole—Dyspepsia—Estradiol—osteoporosis	6.12e-05	0.000156	CcSEcCtD
Aripiprazole—Decreased appetite—Estradiol—osteoporosis	6.05e-05	0.000154	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Estradiol—osteoporosis	6.01e-05	0.000153	CcSEcCtD
Aripiprazole—Fatigue—Estradiol—osteoporosis	6e-05	0.000153	CcSEcCtD
Aripiprazole—Dizziness—Zoledronate—osteoporosis	5.97e-05	0.000152	CcSEcCtD
Aripiprazole—Constipation—Estradiol—osteoporosis	5.95e-05	0.000152	CcSEcCtD
Aripiprazole—Pain—Estradiol—osteoporosis	5.95e-05	0.000152	CcSEcCtD
Aripiprazole—Diarrhoea—Conjugated Estrogens—osteoporosis	5.95e-05	0.000152	CcSEcCtD
Aripiprazole—Nausea—Pamidronate—osteoporosis	5.87e-05	0.00015	CcSEcCtD
Aripiprazole—Dizziness—Conjugated Estrogens—osteoporosis	5.75e-05	0.000147	CcSEcCtD
Aripiprazole—Vomiting—Zoledronate—osteoporosis	5.74e-05	0.000146	CcSEcCtD
Aripiprazole—Feeling abnormal—Estradiol—osteoporosis	5.73e-05	0.000146	CcSEcCtD
Aripiprazole—Rash—Zoledronate—osteoporosis	5.69e-05	0.000145	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Estradiol—osteoporosis	5.69e-05	0.000145	CcSEcCtD
Aripiprazole—Dermatitis—Zoledronate—osteoporosis	5.69e-05	0.000145	CcSEcCtD
Aripiprazole—Headache—Zoledronate—osteoporosis	5.66e-05	0.000144	CcSEcCtD
Aripiprazole—Vomiting—Conjugated Estrogens—osteoporosis	5.53e-05	0.000141	CcSEcCtD
Aripiprazole—Urticaria—Estradiol—osteoporosis	5.53e-05	0.000141	CcSEcCtD
Aripiprazole—Body temperature increased—Estradiol—osteoporosis	5.5e-05	0.00014	CcSEcCtD
Aripiprazole—Abdominal pain—Estradiol—osteoporosis	5.5e-05	0.00014	CcSEcCtD
Aripiprazole—Rash—Conjugated Estrogens—osteoporosis	5.48e-05	0.00014	CcSEcCtD
Aripiprazole—Dermatitis—Conjugated Estrogens—osteoporosis	5.48e-05	0.00014	CcSEcCtD
Aripiprazole—Headache—Conjugated Estrogens—osteoporosis	5.45e-05	0.000139	CcSEcCtD
Aripiprazole—Nausea—Zoledronate—osteoporosis	5.36e-05	0.000137	CcSEcCtD
Aripiprazole—Nausea—Conjugated Estrogens—osteoporosis	5.16e-05	0.000132	CcSEcCtD
Aripiprazole—Hypersensitivity—Estradiol—osteoporosis	5.13e-05	0.000131	CcSEcCtD
Aripiprazole—Asthenia—Estradiol—osteoporosis	4.99e-05	0.000127	CcSEcCtD
Aripiprazole—Pruritus—Estradiol—osteoporosis	4.92e-05	0.000126	CcSEcCtD
Aripiprazole—Diarrhoea—Estradiol—osteoporosis	4.76e-05	0.000121	CcSEcCtD
Aripiprazole—Dizziness—Estradiol—osteoporosis	4.6e-05	0.000117	CcSEcCtD
Aripiprazole—Vomiting—Estradiol—osteoporosis	4.42e-05	0.000113	CcSEcCtD
Aripiprazole—Rash—Estradiol—osteoporosis	4.39e-05	0.000112	CcSEcCtD
Aripiprazole—Dermatitis—Estradiol—osteoporosis	4.38e-05	0.000112	CcSEcCtD
Aripiprazole—Headache—Estradiol—osteoporosis	4.36e-05	0.000111	CcSEcCtD
Aripiprazole—Nausea—Estradiol—osteoporosis	4.13e-05	0.000105	CcSEcCtD
Aripiprazole—CHRM5—Signaling Pathways—IL6R—osteoporosis	8.91e-06	7e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IRS2—osteoporosis	8.9e-06	7e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IGF1—osteoporosis	8.88e-06	6.98e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IRS2—osteoporosis	8.86e-06	6.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—MTHFR—osteoporosis	8.8e-06	6.91e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—ADCY5—osteoporosis	8.79e-06	6.91e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IGF1—osteoporosis	8.79e-06	6.91e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ADCY5—osteoporosis	8.77e-06	6.9e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ADCY5—osteoporosis	8.76e-06	6.89e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ADCY5—osteoporosis	8.74e-06	6.87e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—GPX1—osteoporosis	8.73e-06	6.87e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ADCY5—osteoporosis	8.72e-06	6.85e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—LEP—osteoporosis	8.71e-06	6.85e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—POMC—osteoporosis	8.7e-06	6.84e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—ESR1—osteoporosis	8.7e-06	6.84e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—LEP—osteoporosis	8.67e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—POMC—osteoporosis	8.66e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SPP1—osteoporosis	8.64e-06	6.79e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ADCY5—osteoporosis	8.63e-06	6.78e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—ESR1—osteoporosis	8.62e-06	6.77e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IRS2—osteoporosis	8.61e-06	6.77e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	8.61e-06	6.77e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—POMC—osteoporosis	8.59e-06	6.75e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—TPI1—osteoporosis	8.59e-06	6.75e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—MYC—osteoporosis	8.56e-06	6.73e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—TGFB1—osteoporosis	8.53e-06	6.71e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SPP1—osteoporosis	8.5e-06	6.69e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6R—osteoporosis	8.49e-06	6.67e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SPP1—osteoporosis	8.49e-06	6.67e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IRS2—osteoporosis	8.48e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SPP1—osteoporosis	8.46e-06	6.65e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SPP1—osteoporosis	8.43e-06	6.63e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—LEP—osteoporosis	8.43e-06	6.63e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6R—osteoporosis	8.38e-06	6.59e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IGF1—osteoporosis	8.37e-06	6.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SPP1—osteoporosis	8.35e-06	6.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SPP1—osteoporosis	8.33e-06	6.55e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—ESR1—osteoporosis	8.32e-06	6.54e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—LEP—osteoporosis	8.3e-06	6.52e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—ESR1—osteoporosis	8.27e-06	6.5e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IGF1—osteoporosis	8.26e-06	6.49e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IRS1—osteoporosis	8.12e-06	6.39e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CYP19A1—osteoporosis	8.09e-06	6.36e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—P4HB—osteoporosis	8.07e-06	6.35e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—MTHFR—osteoporosis	8.06e-06	6.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IRS1—osteoporosis	8.05e-06	6.33e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—ESR1—osteoporosis	8.05e-06	6.33e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	8e-06	6.29e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GAPDH—osteoporosis	7.92e-06	6.23e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—ESR1—osteoporosis	7.92e-06	6.23e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—POMC—osteoporosis	7.82e-06	6.15e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IRS2—osteoporosis	7.82e-06	6.14e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IRS1—osteoporosis	7.77e-06	6.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—POMC—osteoporosis	7.75e-06	6.09e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SPP1—osteoporosis	7.74e-06	6.08e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IRS1—osteoporosis	7.73e-06	6.08e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—RAP1A—osteoporosis	7.72e-06	6.07e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IRS2—osteoporosis	7.69e-06	6.05e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IRS2—osteoporosis	7.67e-06	6.03e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—POMC—osteoporosis	7.67e-06	6.03e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IRS2—osteoporosis	7.65e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—LEP—osteoporosis	7.65e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6R—osteoporosis	7.63e-06	6e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CYP19A1—osteoporosis	7.63e-06	6e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IRS2—osteoporosis	7.63e-06	5.99e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—MYC—osteoporosis	7.57e-06	5.95e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6R—osteoporosis	7.56e-06	5.95e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—TGFB1—osteoporosis	7.55e-06	5.94e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IRS2—osteoporosis	7.55e-06	5.94e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IRS2—osteoporosis	7.53e-06	5.92e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—LEP—osteoporosis	7.53e-06	5.92e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IGF1—osteoporosis	7.53e-06	5.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IRS1—osteoporosis	7.52e-06	5.91e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—LEP—osteoporosis	7.51e-06	5.9e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—LEP—osteoporosis	7.49e-06	5.88e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—POMC—osteoporosis	7.48e-06	5.88e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—LEP—osteoporosis	7.46e-06	5.87e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IGF1—osteoporosis	7.46e-06	5.86e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—POMC—osteoporosis	7.45e-06	5.85e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—IL6—osteoporosis	7.44e-06	5.85e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—IL6—osteoporosis	7.43e-06	5.84e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IRS1—osteoporosis	7.4e-06	5.82e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—LEP—osteoporosis	7.39e-06	5.81e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—IL6—osteoporosis	7.38e-06	5.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—LEP—osteoporosis	7.37e-06	5.79e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—ESR1—osteoporosis	7.3e-06	5.74e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6R—osteoporosis	7.3e-06	5.74e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6R—osteoporosis	7.26e-06	5.71e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—POMC—osteoporosis	7.24e-06	5.69e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—IL6—osteoporosis	7.23e-06	5.68e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IGF1—osteoporosis	7.2e-06	5.66e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—ESR1—osteoporosis	7.19e-06	5.65e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ESR1—osteoporosis	7.17e-06	5.64e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IGF1—osteoporosis	7.16e-06	5.63e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ESR1—osteoporosis	7.15e-06	5.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—POMC—osteoporosis	7.13e-06	5.6e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ESR1—osteoporosis	7.12e-06	5.6e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—IL6—osteoporosis	7.11e-06	5.59e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6R—osteoporosis	7.06e-06	5.55e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ESR1—osteoporosis	7.06e-06	5.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ESR1—osteoporosis	7.04e-06	5.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—POMC—osteoporosis	7.03e-06	5.53e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—IL6—osteoporosis	7.02e-06	5.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IRS2—osteoporosis	7e-06	5.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IGF1—osteoporosis	6.97e-06	5.48e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6R—osteoporosis	6.95e-06	5.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IGF1—osteoporosis	6.86e-06	5.39e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—LEP—osteoporosis	6.85e-06	5.38e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IRS1—osteoporosis	6.82e-06	5.36e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—IL6—osteoporosis	6.79e-06	5.34e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—osteoporosis	6.72e-06	5.28e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IRS1—osteoporosis	6.71e-06	5.28e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IRS1—osteoporosis	6.7e-06	5.27e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IRS1—osteoporosis	6.68e-06	5.25e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IRS1—osteoporosis	6.66e-06	5.23e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ADCY5—osteoporosis	6.61e-06	5.2e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IRS1—osteoporosis	6.59e-06	5.18e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GPX1—osteoporosis	6.59e-06	5.18e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IRS1—osteoporosis	6.57e-06	5.17e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—POMC—osteoporosis	6.57e-06	5.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ESR1—osteoporosis	6.54e-06	5.14e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—POMC—osteoporosis	6.47e-06	5.08e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—POMC—osteoporosis	6.45e-06	5.07e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—POMC—osteoporosis	6.45e-06	5.07e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—osteoporosis	6.43e-06	5.06e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—POMC—osteoporosis	6.43e-06	5.06e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—POMC—osteoporosis	6.41e-06	5.04e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6R—osteoporosis	6.41e-06	5.04e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—osteoporosis	6.4e-06	5.03e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—POMC—osteoporosis	6.35e-06	4.99e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—POMC—osteoporosis	6.33e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IGF1—osteoporosis	6.32e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—osteoporosis	6.32e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6R—osteoporosis	6.31e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6R—osteoporosis	6.29e-06	4.95e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6R—osteoporosis	6.27e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6R—osteoporosis	6.25e-06	4.92e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ENO1—osteoporosis	6.24e-06	4.9e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ADCY5—osteoporosis	6.23e-06	4.9e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IGF1—osteoporosis	6.22e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GPX1—osteoporosis	6.21e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IGF1—osteoporosis	6.21e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6R—osteoporosis	6.19e-06	4.87e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IGF1—osteoporosis	6.19e-06	4.86e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6R—osteoporosis	6.18e-06	4.85e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IGF1—osteoporosis	6.17e-06	4.85e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PSMA2—osteoporosis	6.15e-06	4.83e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PSMA5—osteoporosis	6.15e-06	4.83e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IRS1—osteoporosis	6.11e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF1—osteoporosis	6.11e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF1—osteoporosis	6.09e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MTHFR—osteoporosis	6.08e-06	4.78e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—POMC—osteoporosis	5.88e-06	4.62e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MYC—osteoporosis	5.84e-06	4.59e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MYC—osteoporosis	5.84e-06	4.59e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TGFB1—osteoporosis	5.83e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TGFB1—osteoporosis	5.82e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MYC—osteoporosis	5.8e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TGFB1—osteoporosis	5.79e-06	4.55e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—osteoporosis	5.76e-06	4.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6R—osteoporosis	5.74e-06	4.51e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MTHFR—osteoporosis	5.73e-06	4.51e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—osteoporosis	5.7e-06	4.48e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—osteoporosis	5.69e-06	4.47e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MYC—osteoporosis	5.68e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TGFB1—osteoporosis	5.67e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF1—osteoporosis	5.66e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MYC—osteoporosis	5.59e-06	4.39e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TGFB1—osteoporosis	5.57e-06	4.38e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MYC—osteoporosis	5.51e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—osteoporosis	5.51e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—osteoporosis	5.5e-06	4.32e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—osteoporosis	5.48e-06	4.31e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MYC—osteoporosis	5.33e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—osteoporosis	5.33e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—osteoporosis	5.32e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MYC—osteoporosis	5.28e-06	4.15e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—osteoporosis	5.27e-06	4.14e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—osteoporosis	5.24e-06	4.12e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MYC—osteoporosis	5.03e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—osteoporosis	5.02e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.99e-06	3.92e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MYC—osteoporosis	4.96e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—osteoporosis	4.95e-06	3.89e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—POMC—osteoporosis	4.86e-06	3.82e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—osteoporosis	4.83e-06	3.8e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—osteoporosis	4.76e-06	3.74e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—osteoporosis	4.75e-06	3.73e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—osteoporosis	4.73e-06	3.72e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—osteoporosis	4.72e-06	3.71e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—osteoporosis	4.67e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—osteoporosis	4.66e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—POMC—osteoporosis	4.58e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—osteoporosis	4.52e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—osteoporosis	4.51e-06	3.55e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—osteoporosis	4.48e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	4.47e-06	3.51e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—osteoporosis	4.39e-06	3.45e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—osteoporosis	4.39e-06	3.45e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—osteoporosis	4.36e-06	3.43e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—osteoporosis	4.33e-06	3.4e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—osteoporosis	4.33e-06	3.4e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—osteoporosis	4.32e-06	3.39e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—osteoporosis	4.3e-06	3.38e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—osteoporosis	4.29e-06	3.38e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—osteoporosis	4.27e-06	3.36e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—osteoporosis	4.2e-06	3.3e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—osteoporosis	4.19e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	4.18e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—osteoporosis	4.14e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—osteoporosis	4.12e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	4.11e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ADCY5—osteoporosis	4.07e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX1—osteoporosis	4.06e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—osteoporosis	4.01e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—osteoporosis	3.97e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—osteoporosis	3.8e-06	2.99e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—osteoporosis	3.79e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—osteoporosis	3.78e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—osteoporosis	3.75e-06	2.95e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—osteoporosis	3.74e-06	2.94e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—osteoporosis	3.73e-06	2.93e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—osteoporosis	3.73e-06	2.93e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—osteoporosis	3.73e-06	2.93e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—osteoporosis	3.72e-06	2.92e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—osteoporosis	3.72e-06	2.92e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—osteoporosis	3.71e-06	2.92e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—osteoporosis	3.71e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—osteoporosis	3.7e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—osteoporosis	3.67e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—osteoporosis	3.66e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—osteoporosis	3.66e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	3.65e-06	2.87e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—osteoporosis	3.4e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—osteoporosis	3.4e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	3.39e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—osteoporosis	3.37e-06	2.65e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—osteoporosis	3.25e-06	2.56e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—osteoporosis	3.24e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—osteoporosis	3.15e-06	2.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—osteoporosis	3.1e-06	2.43e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—POMC—osteoporosis	3e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—osteoporosis	2.86e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—osteoporosis	2.81e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—osteoporosis	2.8e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—osteoporosis	2.79e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—osteoporosis	2.79e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—osteoporosis	2.76e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.75e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—osteoporosis	2.56e-06	2.01e-05	CbGpPWpGaD
